Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 17, 2017Shock

Earlier Endpoints are Required for Hemorrhagic Shock Trials Among Severely Injured Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

EFErin E. FoxThe University of Texas Health Science Center at HoustonJHJohn B. HolcombCleveland State UniversityCWCharles E. WadeUniversity of Vermont

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fox et al. (2017) studied this question.

synapsesocial.com/papers/6a98140b161d47660415f2e7https://doi.org/10.1097/shk.0000000000000788
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Results of the CONTROL Trial: Efficacy and Safety of Recombinant Activated Factor VII in the Management of Refractory Traumatic Hemorrhage2010 · 347 citations
  2. 2Increasing Trauma Deaths in the United States2014 · 552 citations
  3. 3Human Polymerized Hemoglobin for the Treatment of Hemorrhagic Shock when Blood Is Unavailable: The USA Multicenter Trial2008 · 259 citations
  4. 4Out-of-hospital Hypertonic Resuscitation After Traumatic Hypovolemic Shock2010 · 284 citations
  5. 5Position statement of the American College of Surgeons Committee on Trauma on the National Academies of Sciences, Engineering and Medicine Report, A National Trauma Care System2016 · 68 citations